1. Home
  2. PTIX vs SGD Comparison

PTIX vs SGD Comparison

Compare PTIX & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • SGD
  • Stock Information
  • Founded
  • PTIX 1994
  • SGD 2021
  • Country
  • PTIX United States
  • SGD United States
  • Employees
  • PTIX N/A
  • SGD N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • SGD
  • Sector
  • PTIX Health Care
  • SGD
  • Exchange
  • PTIX Nasdaq
  • SGD Nasdaq
  • Market Cap
  • PTIX 1.9M
  • SGD 1.8M
  • IPO Year
  • PTIX 2016
  • SGD N/A
  • Fundamental
  • Price
  • PTIX $3.03
  • SGD $0.85
  • Analyst Decision
  • PTIX
  • SGD
  • Analyst Count
  • PTIX 0
  • SGD 0
  • Target Price
  • PTIX N/A
  • SGD N/A
  • AVG Volume (30 Days)
  • PTIX 259.3K
  • SGD 43.2K
  • Earning Date
  • PTIX 05-27-2025
  • SGD 01-01-0001
  • Dividend Yield
  • PTIX N/A
  • SGD N/A
  • EPS Growth
  • PTIX N/A
  • SGD N/A
  • EPS
  • PTIX N/A
  • SGD N/A
  • Revenue
  • PTIX N/A
  • SGD $207,552.00
  • Revenue This Year
  • PTIX N/A
  • SGD N/A
  • Revenue Next Year
  • PTIX N/A
  • SGD N/A
  • P/E Ratio
  • PTIX N/A
  • SGD N/A
  • Revenue Growth
  • PTIX N/A
  • SGD N/A
  • 52 Week Low
  • PTIX $2.51
  • SGD $0.65
  • 52 Week High
  • PTIX $26.18
  • SGD $18.53
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 45.51
  • SGD 39.27
  • Support Level
  • PTIX $2.82
  • SGD $0.84
  • Resistance Level
  • PTIX $3.68
  • SGD $1.00
  • Average True Range (ATR)
  • PTIX 0.54
  • SGD 0.11
  • MACD
  • PTIX 0.03
  • SGD 0.00
  • Stochastic Oscillator
  • PTIX 37.16
  • SGD 40.36

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.

Share on Social Networks: